Activity-based selection for enhanced base editor mutational scanning
- 14 October 2025
- journal article
- technical report
- Published by Springer Nature in Nature Genetics
- Vol. 57 (11) , 2920-2929
Abstract
Base editing is a CRISPR-based technology that enables high-throughput, nucleotide-level functional interrogation of the genome that is essential for understanding the genetic basis of human disease and informing therapeutic development. Base editing screens have emerged as a powerful experimental approach, yet significant cell-to-cell variability in editing efficiency introduces noise that may obscure meaningful results. Here we develop a co-selection method that enriches for cells with high base editing activity, substantially increasing editing efficiency at a target locus. We evaluate this activity-based selection method against a traditional screening approach by tiling guide RNAs across TP53, demonstrating its enhanced capacity to pinpoint specific mutations and protein regions of functional importance. We anticipate that this modular selection method will enhance the resolution of base editing screens across many applications.Keywords
This publication has 80 references indexed in Scilit:
- ClinVar: public archive of relationships among sequence variation and human phenotypeNucleic Acids Research, 2013
- Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53BMC Cancer, 2013
- Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assayNature Biotechnology, 2012
- Massively parallel functional dissection of mammalian enhancers in vivoNature Biotechnology, 2012
- Deep mutational scanning: assessing protein function on a massive scaleTrends in Biotechnology, 2011
- Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53British Journal of Cancer, 2010
- High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesisNature Biotechnology, 2009
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical UseCold Spring Harbor Perspectives in Biology, 2009
- TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomesOncogene, 2007
- Mdm-2 binding and TAFII31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21Oncogene, 2002